Member Info for zccax77

Well the auditors will force them to book a contingent liability of 3bn when the next accounts are due, plus the accounts will be qualified.

That rns reads cut and run to me. This entity is under resources to fight the us justice system. Plus there is a Huge backlash against opioid analogue manufacturers especially foreign ones.

Expect this sp to collapse after numis rerate to something closer 0p.

Look at all the gamblers piling into a insolvent non-going concern company yet no one wants to buy saga. The madness of crowds

I think revenue will be 100-150m. But obviously Q1 2018 was almost 300m. Plus will do what IGG did which was compare against previous quarter. The FT and media will compare vs. Q1 2018 and show hugely negative headlines.

INV: Fook me, I was looking to invest here. So glad I didn't due to be lazy.

Esma is great, creates a more sustainable playing field. Mug punters will no longer lose it all and hopefully be repeat customers

One of these might come out and say 40p who knows. I think i will look back in here in a week or so.

Every day this gets more and more tempting. I wonder whether we will get another broker rerating pushing this down.

Up £30k today. 4000p not far away.

Ocado has increased by over 50% in the last two months. Still kicking myself for not buying at 900p. Instead I brought plus500 :-(

No I own them. Will never use a cfd to go into a results rns again. Too risky. MTRo will go up again.

I have a 200k position in this, which I brought at 2200p last year. Will sell above 4000p. This is the only retail game in town.

Where did you get that from?

I would ignore the brokers. This is a cash machine and will continue to deliver cash twice a year.

I am expecting revenue of 400m, 360m is a little low. I am expecting 125m a quarter similar to IGG.

Even if these estimates are correct, then this means this has a pe of 3 after accounting for the gbp240m of cash on the balance sheet and no debt.

The BoD only said it would be materially lower.

Seems too low considering 40% of revenue is non-ESMA and the 30% is professional ESMA.

Why accelerate this? Bad news? I thought it would be more beneficial for them to delay and ramp up the share repurchases in the meantime. So between quarter close and results they only have 9 work days.